Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...
Read Full NewsPatients with breast cancer living in states with expanded Medicaid eligibility, have seen survival gains, raising more concerns about the impact of recent changes to the program.
The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.
Therapeutic vaccines are advancing in oncology and HIV, with the aim of retraining immune responses to target tumors and persistent viral reservoirs with precision.
Ten-year survival data support salvage focal therapy as an option for patients with localized recurrence after prostate cancer radiotherapy.
Researchers asked more than 2000 women if they preferred at-home vaginal self-sampling over clinic-based testing to screen for cervical cancer.
‘Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.
Researchers compared outcomes of stereotactic radiation and hippocampal-avoidance whole brain radiation in patients with 5-20 brain metastases.
1.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
2.
Two medications might work better for breast cancers that are resistant to one.
3.
Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control
4.
Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects
5.
New research points out a promising strategy for treating metastatic medulloblastoma
1.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
2.
Neutrophil Profiling and AI Rewrites Cancer Diagnosis
3.
Obesity as a major risk factor for cancer
4.
Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence
5.
The Miracle of Tenecteplase: How This Drug Is Saving Lives
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
2.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
5.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge